Chinook Therapeutics Inc. (KDNY)
NASDAQ: KDNY
· Real-Time Price · USD
40.39
0.09 (0.22%)
At close: Aug 10, 2023, 10:00 PM
Chinook Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -10.27 | -6.8 | -7.34 | -6.14 | -7.2 | -7.53 | 27.93 | -4.64 | -3.64 | -4.4 |
PEG Ratio | -0.97 | 1.51 | -0.65 | -0.2 | -0.56 | 0.02 | -0.23 | 0.16 | -0.36 | 0.15 |
PS Ratio | 2.73K | 895.39 | 3.54K | 532.80 | 2.59K | 353.89 | 16.45 | 142.47K | 18.22K | 1.87K |
PB Ratio | 7.70 | 3.97 | 4.10 | 2.81 | 2.14 | 2.24 | 1.86 | 2.11 | 2.09 | 2.18 |
P/FCF Ratio | -44.5 | -31.72 | -48.35 | -51.89 | -35.15 | -38.03 | -36.83 | -22.36 | -22.45 | -22.83 |
P/OCF Ratio | -44.95 | -32.3 | -49.24 | -52.64 | -35.41 | -38.61 | -37.46 | -23.04 | -22.58 | -23.32 |
OCF/S Ratio | -60.71 | -27.72 | -71.93 | -10.12 | -73.25 | -9.17 | -0.44 | -6.18K | -806.82 | -80 |
Debt / Equity Ratio | 0.10 | 0.09 | 0.09 | 0.09 | 0.08 | 0.10 | 0.10 | 0.17 | 0.14 | 0.14 |
Quick Ratio | 5.82 | 7.04 | 7.59 | 8.53 | 12.60 | 7.82 | 7.50 | 7.91 | 8.55 | 9.05 |
Current Ratio | 5.82 | 7.04 | 7.59 | 8.53 | 12.60 | 7.82 | 7.50 | 7.91 | 8.55 | 9.05 |
Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.09 | 0.00 | 0.00 | 0.00 |
Interest Coverage | n/a | n/a | -12.43 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.19 | -0.15 | -0.14 | -0.11 | -0.07 | -0.07 | 0.02 | -0.11 | -0.14 | -0.12 |
Return on Assets | -0.14 | -0.11 | -0.11 | -0.09 | -0.06 | -0.06 | 0.01 | -0.08 | -0.1 | -0.09 |
Return on Invested Capital | -0.16 | -0.13 | -0.12 | -0.1 | -0.07 | -0.06 | 0.02 | -0.08 | -0.11 | -0.1 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.57 | 0.76 | 0.16 | 0.83 | -0.03 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Net Profit Margin | -66.41 | -32.92 | -120.7 | -21.71 | -90.07 | -11.75 | 0.15 | -7.67K | -1.25K | -106.03 |
Pretax Profit Margin | -68.41 | -31.9 | -112.22 | -22.39 | -85.93 | -11.46 | 0.24 | -7.77K | -1.27K | -106.03 |
Operating Profit Margin | -72.05 | -33.6 | -117 | -23.06 | -87.76 | -11.43 | 0.24 | -7.75K | -1.27K | -105.83 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -69.34 | -34.48 | -92.55 | -16.36 | -94.23 | -11.71 | 0.47 | -7.39K | -513.03 | -91.87 |